PSMA ADC consists of a fully human monoclonal IgG1 antibody conjugated to monomethyl auristatin E (MMAE) through a dipeptide linker (valine-citrulline) that disintegrates inside the tumor cell. This evidence concerns the gene FOLH1 and neoplasm.